CompanyDrug

LianBio Initiates Phase I Study of SHP2 Inhibitor BBP-398 in China

CompanyDeals

Innovex Medical Files for IPO in Hong Kong to Boost Product Development

CompanyDrug

NMPA Conditionally Approves Yingli Pharma’s Linperlisib for Lymphoma

CompanyDrug

Ascentage Pharma Gains CDE Approval for Phase I Study of APG-5918

Policy / Regulatory

China Releases 14th Five-Year Plan for National Health Informatization

Company

Zai Lab Reports 33% YOY Revenue Growth in Q3 2022

CompanyDeals

GSK Partners with CASPC to Advance HIV Sustained Care Advocacy in China

CompanyDrug

3SBio Receives NMPA Review for Pediatric ITP Thrombopoietin Filing

CompanyDeals

Boston Scientific Partners with Omron for Atrial Fibrillation Management

CompanyDeals

Takeda Partners with AWS and Accenture to Launch Innovation Incubator at CIIE

CompanyDrug

Betta Pharmaceuticals’ BPI-D0316 Shows Promise in Phase II/III Lung Cancer Study

Company

BeiGene Reports 88% YOY Revenue Growth in Q3 2022